Pharma supply chains

Ypsomed CEO: US production to begin in 2027

This content was published on Aug 30, 2025 Ypsomed CEO explains why US tariffs are not a worry and why he sees more growth from diabetes and obesity treatments such as Ozempic.

Drug pricing

How pharma became Switzerland’s Achilles heel in US trade talks

This content was published on Aug 6, 2025 The pharmaceutical industry’s strength has made it a key vulnerability for Switzerland in trade talks with the US.

Roche CEO: 'Agreement between Bern and Washington within days, if not hours'

Drug pricing

Switzerland very close to tariff deal with the US, says Roche CEO

This content was published on Jul 25, 2025 An understanding between Berne and Washington in the dispute over customs barriers is close: Roche CEO Thomas Schinecker is convinced of this.

Drug pricing

Roche boss says ‘very easy’ to cut US drug prices by 50%

This content was published on Jul 24, 2025 Swiss pharma group Roche is in talks with Washington to bypass middlemen and sell directly to consumers.

A machine dispenses pharmaceutical capsules into blister packs.

Drug pricing

Potential US tariff exemption for Swiss pharma is not necessarily a boon

This content was published on Jul 22, 2025 Donald Trump is pressuring the pharma industry with tariffs. But experts say that tariffs will have less impact on the industry than pricing.

Pharma supply chains

Swiss pharma firm Sandoz invests $440 million in Slovenia

This content was published on Jul 2, 2025 Sandoz is investing $440 million in Slovenia for new biosimilar centers, aiming to tap into a rapidly growing market.

Janssen plant in Bern threatened with closure, 300 employees affected

Medicine access

Janssen vaccine maker considers closing Bern factory

This content was published on Jul 2, 2025 Janssen may close its historic Bern factory due to vaccine challenges and new Dutch plant plans.

A pharmacist with a customer in France offering a generic drug.

Pharma supply chains

How US tariffs could disrupt the generic drugs supply chain

This content was published on Jul 1, 2025 US tariffs on generics could raise drug prices and accentuate shortages. That's not what US President Donald Trump had in mind.

Medicine access

Sandoz board chair ‘convinced that common sense will ultimately prevail’ on US pharma tariffs

This content was published on Jun 28, 2025 In an exclusive interview with Swissinfo, Sandoz chair Gilbert Ghostine says he remains optimistic despite looming tariff hikes.

Pharma supply chains

Swiss exports to the US plummeted in May

This content was published on Jun 19, 2025 The Swiss export industry suffered another double-digit decline in May. Exports to the US collapsed.

Pharma supply chains

Popular Stories

Most Discussed

Pharma supply chains

More

Ypsomed CEO: US production to begin in 2027

More

How pharma became Switzerland’s Achilles heel in US trade talks

More

Switzerland very close to tariff deal with the US, says Roche CEO

More

Roche boss says ‘very easy’ to cut US drug prices by 50%

More

Potential US tariff exemption for Swiss pharma is not necessarily a boon

More

Swiss pharma firm Sandoz invests $440 million in Slovenia

More

Janssen vaccine maker considers closing Bern factory

More

How US tariffs could disrupt the generic drugs supply chain

More

Sandoz board chair ‘convinced that common sense will ultimately prevail’ on US pharma tariffs

More

Swiss exports to the US plummeted in May

Popular Stories

Most Discussed